Private equity market AUM set to more than double, while secondaries (13.1%) predicted to see strongest annualized growth in forecast period of 2023 to 2029
Presentations to highlight progress in development of IND candidates ZW220 and ZW251 based on Zymeworks'proprietary antibody-drug conjugate development platforms
Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE: PM), today announces the sale of its subsidiary Vectura Group Ltd. (Vect......
